Pharmaceutical Packaging Systems – Page 24

Lane Qualification and Cold Chain Packaging Strategy

Identifying early signs of failure in cold chain packaging systems is essential for maintaining product integrity. Below are some common symptoms or signals that may indicate issues in the cold…

How to Design a GMP Packaging Line That Prevents Mix-Ups from Day One

Recognizing symptoms or signals of potential mix-ups is crucial for preemptive action. Common signs include:Click to read the full article.

E&L Considerations for Sterile Product Container Closure Integrity

Understanding Extractables and Leachables for Sterile Product Container Closure Integrity In the realm of pharmaceutical manufacturing, ensuring the integrity of sterile product container closures is a critical consideration. Among various…

Cold Chain Packaging for Cell and Gene Therapy Products

Recognizing deviations in cold chain packaging systems is the first step toward maintaining product integrity. Observable symptoms may include:Click to read the full article.

Packaging Line Scale-Up from Pilot Runs to Commercial Throughput

When moving from pilot packaging to commercial packaging, a range of symptoms can indicate potential issues within the packaging line. It is crucial to be aware of these signals to…

How to Create an E&L Master Plan for a Product Portfolio

Recognizing the symptoms of potential extractables and leachables issues is the first step in averting significant problems. Common signals that may indicate E&L concerns include:Click to read the full article.

Cold Chain Packaging for Injectable Biologics

Being vigilant for signs of potential temperature excursions is essential for maintaining product quality. Common symptoms and signals include:Click to read the full article.

Risk-Based URS for Pharmaceutical Packaging Line Equipment

Detecting symptoms of inadequacies in your packaging equipment URS can often correlate with various signals observed either on the production floor or through laboratory analysis. Common signals include:Click to read…

Extractables and Leachables SOP: Required Sections and Evidence

In the case considered, a pharmaceutical manufacturer experienced an unexpected spike in product batch deviations linked to an increase in reported particulate matter in sterile drug solutions packaged in newly…

How to Perform Worst-Case Testing for Cold Chain Packs

Recognizing symptoms that indicate potential failures in cold chain packaging is essential. Common signals include:Click to read the full article.

Blister Packaging Line Design: Critical Controls for Speed, Seal Integrity, and Serialization

Identifying symptoms or signals of malfunction in blister packaging can be critical in instigating timely interventions. Here are several key symptoms to observe:Click to read the full article.

E&L Inspection Readiness: What Documents and Trends to Prepare

Identifying the symptoms of E&L contamination is a crucial first step in developing an effective response. Symptoms may manifest themselves as discrepancies during product testing, complaints post-distribution, or unexpected results…